Company Filing History:
1 out of 1 
1 out of 832,812 Years Active: 2003
Title: **Girish G Parikh: Innovator in Immunomodulatory Agents**
Introduction
Girish G Parikh is an accomplished inventor based in Maharashtra, India, known for his significant contributions to the field of pharmaceuticals. With two patents to his name, his innovations focus on novel oligospirostanosides, compounds that have shown potential as immunomodulatory agents.
Latest Patents
Parikh's latest patents showcase his expertise in the isolation and application of oligospirostanosides. The first patent describes a process for the isolation of a novel oligospirostanoside, specifically a compound identified as 3-0-[α-L-rhamnopyranosyl-(1→2)-α-L-rhamnopyranosyl-(1→4)-0-β-D-glucopyranosyl]-25(S)-5β-spirostan-3β-ol. This compound has been isolated and biologically evaluated for its immunomodulatory properties.
The second patent is centered around the same oligospirostanoside and details a pharmaceutical composition containing it, along with a method for immunomodulation using the oligospirostanoside by administering a pharmaceutically effective amount.
Career Highlights
Throughout his career, Girish G Parikh has demonstrated a commitment to innovation in pharmaceutical research. His work at Zandu Pharmaceutical Works Ltd. showcases his dedication to developing effective medical solutions that address immunological concerns.
Collaborations
Parikh has fostered collaborative relationships within the industry, notably with coworkers such as Sukhdev Swami Handa and Om Prakash Suri. These collaborations have played a significant role in advancing his research and contributing to the successful development of his patents.
Conclusion
Girish G Parikh stands out as an innovative inventor in the pharmaceutical industry, with a focus on immunomodulatory agents through his patented oligospirostanosides. His contributions not only highlight his expertise and creativity but also pave the way for potential advancements in medical treatments. Through continued research and collaboration, Parikh remains at the forefront of innovation in his field.